Related Experiment Video
Updated: Aug 24, 2026

Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death
Published on: December 27, 2016
Nuclear export of phosphorylated galectin-3 regulates its antiapoptotic activity in response to chemotherapeutic
Yukinori Takenaka1, Tomoharu Fukumori, Tadashi Yoshii
1Tumor Progression and Metastasis Program, Karmanos Cancer Institute, Detroit, Michigan 48201, USA.
Abstract:
Galectin-3 (Gal-3), a member of the beta-galactoside binding protein family containing the NWGR antideath motif of the Bcl-2 protein family, is involved in various aspects of cancer progression. Previously, it has been shown that the antiapoptotic activity of Gal-3 is regulated by the phosphorylation at Ser(6) by casein kinase 1 (CK1). Here we questioned how phosphorylation at Ser(6) regulates Gal-3 function. We have generated serine-to-alanine (S6A) and serine-to-glutamic acid (S6E) Gal-3 mutants and transfected them into the BT-549 human breast carcinoma cell line, which does not express Gal-3. BT-549 cell clones expressing wild-type (wt) and mutant Gal-3 were exposed to chemotherapeutic anticancer drugs. In response to the apoptotic insults, phosphorylated wt Gal-3 was exported from the nucleus to the cytoplasm and protected the BT-549 cells from drug-induced apoptosis while nonphosphorylated mutant Gal-3 neither was exported from the nucleus nor protected BT-549 cells from drug-induced apoptosis. Furthermore, leptomycin B, a nuclear export inhibitor, increased the cisplatin-induced apoptosis of Gal-3 expressing BT-549 cells. These results suggest that Ser(6) phosphoryaltion acts as a molecular switch for its cellular translocation from the nucleus to the cytoplasm and, as a result, regulates the antiapoptotic activity of Gal-3.
Insights
Galectin-3 phosphorylation at Serine 6 controls its movement from the nucleus to the cytoplasm, regulating its anti-cancer drug resistance and cell survival.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Galectin-3 (Gal-3) is implicated in cancer progression.
- Gal-3's anti-apoptotic function is modulated by phosphorylation at Serine 6 (Ser6) by casein kinase 1 (CK1).
Purpose of the Study:
- To investigate how Ser6 phosphorylation regulates Gal-3 function.
- To determine the role of Gal-3 nuclear-cytoplasmic translocation in its anti-apoptotic activity.
Main Methods:
- Generated serine-to-alanine (S6A) and serine-to-glutamic acid (S6E) Gal-3 mutants.
- Transfected wild-type (wt) and mutant Gal-3 into BT-549 human breast carcinoma cells.
- Treated cells with chemotherapeutic drugs and leptomycin B (nuclear export inhibitor).
Main Results:
- Phosphorylated wt Gal-3 translocated from the nucleus to the cytoplasm upon drug treatment, protecting cells from apoptosis.
- Non-phosphorylated Gal-3 mutants remained in the nucleus and did not confer protection.
- Inhibiting nuclear export with leptomycin B increased drug-induced apoptosis.
Conclusions:
- Ser6 phosphorylation acts as a molecular switch for Gal-3 translocation.
- Cytoplasmic localization of Gal-3, triggered by phosphorylation, mediates its anti-apoptotic effects.
- Targeting Gal-3 nuclear export could enhance cancer chemotherapy efficacy.
Related Concept Videos
Nuclear Export
NES are of three types- the canonical 10-residue long leucine-rich signal and other...
Regulation of Nuclear Protein Sorting
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Amplifying Signals via Enzymatic Cascade
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
